PBMs Hinder Access To Generics And Biosimilars, Finds FTC’s Investigation

The Biosimilars Forum And AAM Commend FTC, While PBM Association Hits Back

 
• By Urtė Fultinavičiūtė
  
Illustration showing blocked path by a wall
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Policy & Regulation

More from Generics Bulletin